B
Babithajain
About Babithajain
Data last updated:
Babithajain is a Designated Partner at Remedi Speciality Medicines Llp (since 2021). The companies operate in Pharma. Earlier, Babithajain was a Director at Tricept Pharmaceuticals Private Limited (2017–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 01 Apr 2021 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Sep 2017 | 2017 | ₹16.4 Lakh (FY 2022) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Babithajain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Jain Shanta | 07132216 | Remedi Speciality Medicines Llp | Designated Partner |
| Ashishkumar | 09149489 | Remedi Speciality Medicines Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Babithajain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babithajain
Babithajain currently holds 1 directorship: Remedi Speciality Medicines Llp (Designated Partner, since 01 Apr 2021).
Babithajain was first appointed on 13 Sep 2017 as Director at Tricept Pharmaceuticals Private Limited. The most recent appointment on record is 01 Apr 2021 at Remedi Speciality Medicines Llp.
Babithajain held 1 earlier board appointment: Tricept Pharmaceuticals Private Limited (Director, 13 Sep 2017 to 15 Mar 2022).
The current boards of Babithajain's companies include Anil Kumar Jain Shanta (Remedi Speciality Medicines Llp), Ashishkumar (Remedi Speciality Medicines Llp).